Magenta Therapeutics
A biotechnology company developing therapeutics that unlock the power of stem cell biology.
Launch date
Employees
Market cap
$42.4m
Enterprise valuation
($35m) (Public information from Sep 2023)
Share price
$28.1 MGTA
Cambridge Massachusetts (HQ)
Financials
Estimates*
| USD | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| EBITDA | (35.0m) | (59.0m) | (81.0m) | (77.0m) | (73.0m) | (79.0m) |
| Profit | (35.0m) | (58.0m) | (77.0m) | (75.0m) | (71.0m) | (76.0m) |
| EV / EBITDA | - | -0.8x | -5.4x | -3.0x | -1.1x | 0.7x |
| R&D budget | 27.9m | 41.3m | 59.2m | 50.6m | 46.8m | 55.1m |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Spinout | ||
$48.5m | Series A | ||
$50.0m | Series B | ||
$52.0m | Series C | ||
| N/A | N/A | IPO | |
* | N/A | $100m | Post IPO Equity |
* | N/A | Acquisition | |
| Total Funding | $150m | ||
Related Content
Recent News about Magenta Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.